Differential response to scrambler therapy by neuropathic pain phenotypes

Abstract Scrambler therapy is a noninvasive electroanalgesia technique designed to remodulate the pain system. Despite growing evidence of its efficacy in patients with neuropathic pain, little is known about the clinical factors associated with treatment outcome. We conducted a prospective, open-la...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Young Gi Min, Hyun Seok Baek, Kyoung-Min Lee, Yoon-Ho Hong
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/f4fa45de515c4417a7f088efae2994e7
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f4fa45de515c4417a7f088efae2994e7
record_format dspace
spelling oai:doaj.org-article:f4fa45de515c4417a7f088efae2994e72021-12-02T15:43:23ZDifferential response to scrambler therapy by neuropathic pain phenotypes10.1038/s41598-021-89667-62045-2322https://doaj.org/article/f4fa45de515c4417a7f088efae2994e72021-05-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-89667-6https://doaj.org/toc/2045-2322Abstract Scrambler therapy is a noninvasive electroanalgesia technique designed to remodulate the pain system. Despite growing evidence of its efficacy in patients with neuropathic pain, little is known about the clinical factors associated with treatment outcome. We conducted a prospective, open-label, single-arm trial to assess the efficacy and safety of scrambler therapy in patients with chronic neuropathic pain of various etiologies. A post-hoc analysis was performed to investigate whether cluster analysis of the Neuropathic Pain Symptom Inventory (NPSI) profiles could identify a subgroup of patients regarding neuropathic pain phenotype and treatment outcome. Scrambler therapy resulted in a significant decrease in the pain numerical rating scale (NRS) score over 2 weeks of treatment (least squares mean of percentage change from baseline, − 15%; 95% CI − 28% to − 2.4%; p < 0.001). The mean score of Brief Pain Inventory (BPI) interference subdimension was also significantly improved (p = 0.022), while the BPI pain composite score was not. Hierarchical clustering based on the NPSI profiles partitioned the patients into 3 clusters with distinct neuropathic pain phenotypes. Linear mixed-effects model analyses revealed differential response to scrambler therapy across clusters (p = 0.003, pain NRS; p = 0.072, BPI interference subdimension). Treatment response to scrambler therapy appears different depending on the neuropathic pain phenotypes, with more favorable outcomes in patients with preferentially paroxysmal pain rather than persistent pain. Further studies are warranted to confirm that capturing neuropathic pain phenotypes can optimize the use of scrambler therapy.Young Gi MinHyun Seok BaekKyoung-Min LeeYoon-Ho HongNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Young Gi Min
Hyun Seok Baek
Kyoung-Min Lee
Yoon-Ho Hong
Differential response to scrambler therapy by neuropathic pain phenotypes
description Abstract Scrambler therapy is a noninvasive electroanalgesia technique designed to remodulate the pain system. Despite growing evidence of its efficacy in patients with neuropathic pain, little is known about the clinical factors associated with treatment outcome. We conducted a prospective, open-label, single-arm trial to assess the efficacy and safety of scrambler therapy in patients with chronic neuropathic pain of various etiologies. A post-hoc analysis was performed to investigate whether cluster analysis of the Neuropathic Pain Symptom Inventory (NPSI) profiles could identify a subgroup of patients regarding neuropathic pain phenotype and treatment outcome. Scrambler therapy resulted in a significant decrease in the pain numerical rating scale (NRS) score over 2 weeks of treatment (least squares mean of percentage change from baseline, − 15%; 95% CI − 28% to − 2.4%; p < 0.001). The mean score of Brief Pain Inventory (BPI) interference subdimension was also significantly improved (p = 0.022), while the BPI pain composite score was not. Hierarchical clustering based on the NPSI profiles partitioned the patients into 3 clusters with distinct neuropathic pain phenotypes. Linear mixed-effects model analyses revealed differential response to scrambler therapy across clusters (p = 0.003, pain NRS; p = 0.072, BPI interference subdimension). Treatment response to scrambler therapy appears different depending on the neuropathic pain phenotypes, with more favorable outcomes in patients with preferentially paroxysmal pain rather than persistent pain. Further studies are warranted to confirm that capturing neuropathic pain phenotypes can optimize the use of scrambler therapy.
format article
author Young Gi Min
Hyun Seok Baek
Kyoung-Min Lee
Yoon-Ho Hong
author_facet Young Gi Min
Hyun Seok Baek
Kyoung-Min Lee
Yoon-Ho Hong
author_sort Young Gi Min
title Differential response to scrambler therapy by neuropathic pain phenotypes
title_short Differential response to scrambler therapy by neuropathic pain phenotypes
title_full Differential response to scrambler therapy by neuropathic pain phenotypes
title_fullStr Differential response to scrambler therapy by neuropathic pain phenotypes
title_full_unstemmed Differential response to scrambler therapy by neuropathic pain phenotypes
title_sort differential response to scrambler therapy by neuropathic pain phenotypes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/f4fa45de515c4417a7f088efae2994e7
work_keys_str_mv AT younggimin differentialresponsetoscramblertherapybyneuropathicpainphenotypes
AT hyunseokbaek differentialresponsetoscramblertherapybyneuropathicpainphenotypes
AT kyoungminlee differentialresponsetoscramblertherapybyneuropathicpainphenotypes
AT yoonhohong differentialresponsetoscramblertherapybyneuropathicpainphenotypes
_version_ 1718385847051485184